Synthesis, Crystal Structure and Bioactivity of 1-(3-((benzo [D] [1,3] Dioxol-5-Yloxy)Methyl)Phenethyl)-4-Phenylpiperidin-4-Ol
Xu Xing-Jie,Xu Wei,Chen Hong,Shao Bin-Hao
DOI: https://doi.org/10.14102/j.cnki.0254-5861.2011-0787
IF: 0.847
2015-01-01
Chinese journal of structural chemistry
Abstract:The title compound 1-(3-((benzo[d][1,3]dioxo1-5-yloxy)methyl)phenethyl)-4-phenylpiperidin-4-ol (4, C27H29NO4, M-r = 431.51) was synthesized by a four -step reaction and characterized by H-1 NMR, C-13 NMR, elemental analysis and single -crystal X-ray diffraction. The crystal is of triclinic, space group P1 with a = 5.8033(12), b = 10.705(2), c = 18.393(4) angstrom, alpha = 83.44(3), beta= 82.71(3), gamma = 88.88 (3)degrees, V= 1126.0(4) angstrom(3), Z= 1, Dc= 1.273 g/cm(3), S = 1.070, mu= 0.681 mm(-1), F(000) = 460, R = 0.0618 and wR = 0.1619 for 6452 observed reflections with I> 2 sigma(I). Geometry conformations revealed that the dihedral angle between benzodioxole and aromatic planes contributed to the formation of C-H center dot center dot center dot pi interactions. Hydrogen bonds and van der waals interactions were observed to stabilize the three-dimensional packing structure. The compound showed a moderate inhibitory activity against the prostate cancer cells.